Coherus BioSciences Inc (CHRS)
1.51
-0.06
(-3.82%)
USD |
NASDAQ |
Jan 08, 16:00
1.47
-0.04
(-2.65%)
Pre-Market: 09:06
Coherus BioSciences Shareholders Equity (Quarterly): -87.97M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amgen Inc | 7.527B |
| Eli Lilly and Co | 14.24B |
| CEL-SCI Corp | 8.473M |
| AIM ImmunoTech Inc | 2.912M |
| IGC Pharma Inc | 7.377M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 505.00M |
| Total Liabilities (Quarterly) | 592.97M |
| Debt to Equity Ratio | -3.007 |
| Current Ratio | 1.248 |
| Net Debt Paydown Yield | 34.67% |